Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.1 USD | +0.69% | +2.00% | -9.25% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Financials (USD)
Sales 2024 * | 48.84M | Sales 2025 * | 53.68M | Capitalization | 68.85M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.41 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.28 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.79% |
Latest transcript on Champions Oncology, Inc.
1 day | +0.70% | ||
1 week | +2.88% | ||
Current month | +3.37% | ||
1 month | -2.97% | ||
3 months | -24.74% | ||
6 months | -20.36% | ||
Current year | -9.87% |
Managers | Title | Age | Since |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 10-10-25 |
Brady Davis
PSD | President | - | 23-10-16 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 07-12-31 |
Scott Tobin
BRD | Director/Board Member | 53 | 11-06-26 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 5.1 | +0.69% | 789 |
24-04-18 | 5.065 | +0.70% | 1,206 |
24-04-17 | 5.03 | -3.73% | 4,183 |
24-04-16 | 5.225 | +4.50% | 398 |
24-04-12 | 5 | +1.56% | 13,368 |
Delayed Quote Nasdaq, April 18, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-9.87% | 68.85M | |
-1.82% | 41.35B | |
+42.04% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- CSBR Stock